Skip to content
Trial Eligibility
Menu

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

NCT07602582

This study is recruiting at 42 US sites in 14 states, according to its ClinicalTrials.gov record last updated .

Summary

The main purpose of this study is to determine if participants who previously took donanemab get clinical benefit when they receive annual doses. For each participant, the study will last up to 2.5 years and will include 6 visits.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Alzheimer Disease
  • Dementia
  • Plaque, Amyloid

Eligibility basics and study details

Study type
Interventional
Phase
Phase 3
Ages
55 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Eli Lilly and Company
Last updated on ClinicalTrials.gov
July 7, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 8

  • Care Access - Huntington Beach · Huntington Beach, CA
  • Irvine Clinical Research · Irvine, CA
  • Healthy Brain Clinic · Long Beach, CA
  • Artemis Institute for Clinical Research · Riverside, CA
  • Clinical Trials Research · Sacramento, CA
  • Syrentis Clinical Research · Santa Ana, CA
  • Providence Medical Foundation · Santa Rosa, CA
  • Infectious Disease Doctors Medical Group, APC · Walnut Creek, CA

Florida · 18

  • VIN - Aventura · Aventura, FL
  • Bradenton Research Center, Inc. · Bradenton, FL
  • Finlay Medical Research · Greenacres City, FL
  • Jacksonville Center for Clinical Research · Jacksonville, FL
  • K2 Medical Research ORLANDO · Maitland, FL
  • Merritt Island Medical Research, LLC · Merritt Island, FL
  • Finlay Medical Research · Miami, FL
  • VIN-Andrew Lerman · Miami, FL
  • Indago Research & Health Center, Inc · Miami Lakes, FL
  • Adult Medicine of Lake County, Inc. · Mt. Dora, FL
  • Suncoast Clinical Research, Inc. · New Port Richey, FL
  • Charter Research - Orlando · Orlando, FL
  • Headlands Research Orlando · Orlando, FL
  • Emerald Coast Neurology - Airport Boulevard · Pensacola, FL
  • Progressive Medical Research · Port Orange, FL
  • Care Access - Tampa · Tampa, FL
  • Charter Research - The Villages · The Villages, FL
  • Conquest Research · Winter Park, FL

Georgia · 2

  • Center for Advanced Research & Education · Gainesville, GA
  • North Georgia Clinical Research · Woodstock, GA

Idaho · 1

  • Northwest Clinical Trials · Boise, ID

Illinois · 1

  • Great Lakes Clinical Trials - Andersonville · Chicago, IL

Indiana · 2

  • Care Access - South Indianapolis · Indianapolis, IN
  • Josephson Wallack Munshower Neurology, PC · Indianapolis, IN

Louisiana · 1

  • Care Access - Lake Charles (Bayou Pines) · Lake Charles, LA

Massachusetts · 1

  • Boston Center for Memory · Newton, MA

Missouri · 1

  • Citizens Memorial Hospital District · Bolivar, MO

Nevada · 1

  • Vector Clinical Trials · Las Vegas, NV

New Jersey · 1

  • The Cognitive and Research Center of New Jersey · Springfield, NJ

Ohio · 1

  • Care Access - Lima · Lima, OH

Texas · 2

  • Gadolin Research · Beaumont, TX
  • The University of Texas Health Science Center at Houston · Houston, TX

Washington · 2

  • Northwest Clinical Research Center · Bellevue, WA
  • Universal Research Group · Tacoma, WA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.